530 related articles for article (PubMed ID: 28608612)
1. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.
Akay CL; Albarracin C; Torstenson T; Bassett R; Mittendorf EA; Yi M; Kuerer HM; Babiera GV; Bedrosian I; Hunt KK; Hwang RF
Breast J; 2018 Jan; 24(1):28-34. PubMed ID: 28608612
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
4. False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: a retrospective analysis of patients in a single Asian institution.
Wong J; Yong WS; Thike AA; Iqbal J; Salahuddin AS; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2015 Jul; 68(7):536-40. PubMed ID: 25855801
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative sentinel lymph node evaluation in patients with node-positive breast cancer status post neoadjuvant systemic therapy - An institutional experience.
Laury RJ; Gloyeske N; Mettman D; Wagner JL; Fan F
Ann Diagn Pathol; 2022 Oct; 60():152012. PubMed ID: 35908331
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Intraoperative Frozen Section of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Carcinoma.
Grabenstetter A; Moo TA; Hajiyeva S; Schüffler PJ; Khattar P; Friedlander MA; McCormack MA; Raiss M; Zabor EC; Barrio A; Morrow M; Edelweiss M
Am J Surg Pathol; 2019 Oct; 43(10):1377-1383. PubMed ID: 31219817
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
[TBL] [Abstract][Full Text] [Related]
9. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
Barron AU; Hoskin TL; Boughey JC
Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
[TBL] [Abstract][Full Text] [Related]
10. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
[TBL] [Abstract][Full Text] [Related]
11. The intraoperative assessment of sentinel nodes - Standards and controversies.
van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
[TBL] [Abstract][Full Text] [Related]
12. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
13. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
Ballehaninna UK; Chamberlain RS
Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
[TBL] [Abstract][Full Text] [Related]
14. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
Mittendorf EA; Hunt KK; Boughey JC; Bassett R; Degnim AC; Harrell R; Yi M; Meric-Bernstam F; Ross MI; Babiera GV; Kuerer HM; Hwang RF
Ann Surg; 2012 Jan; 255(1):109-15. PubMed ID: 22167004
[TBL] [Abstract][Full Text] [Related]
16. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
17. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
Ding J; Jiang L; Wu W
Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
Ozkurt E; Yardımcı E; Tükenmez M; Ersoy YE; Yilmaz R; Cabioğlu N; Karanlık H; Kulle CB; Malya FU; Önder S; Gucin Z; İğci A; Özmen V; Dinççağ AS; Müslümanoğlu M
Breast J; 2019 Jan; 25(1):96-102. PubMed ID: 30419607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
